These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31544490)

  • 1. Nanoformulations for glioblastoma multiforme: a new hope for treatment.
    Ortiz R; Cabeza L; Perazzoli G; Jimenez-Lopez J; García-Pinel B; Melguizo C; Prados J
    Future Med Chem; 2019 Sep; 11(18):2459-2480. PubMed ID: 31544490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology to augment immunotherapy for the treatment of glioblastoma multiforme.
    Ung N; Yang I
    J Neurooncol; 2015 Jul; 123(3):473-81. PubMed ID: 26070553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles for hyperthermic therapy: synthesis strategies and applications in glioblastoma.
    Verma J; Lal S; Van Noorden CJ
    Int J Nanomedicine; 2014; 9():2863-77. PubMed ID: 24959075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaches to physical stimulation of metallic nanoparticles for glioblastoma treatment.
    Pinel S; Thomas N; Boura C; Barberi-Heyob M
    Adv Drug Deliv Rev; 2019 Jan; 138():344-357. PubMed ID: 30414495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging treatment strategies for glioblastoma multiforme.
    Carlsson SK; Brothers SP; Wahlestedt C
    EMBO Mol Med; 2014 Nov; 6(11):1359-70. PubMed ID: 25312641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnology meets glioblastoma multiforme: Emerging therapeutic strategies.
    Liu D; Dai X; Ye L; Wang H; Qian H; Cheng H; Wang X
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Jan; 15(1):e1838. PubMed ID: 35959642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel sights on therapeutic, prognostic, and diagnostics aspects of non-coding RNAs in glioblastoma multiforme.
    Mekala JR; Adusumilli K; Chamarthy S; Angirekula HSR
    Metab Brain Dis; 2023 Aug; 38(6):1801-1829. PubMed ID: 37249862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioblastoma Multiforme, Diagnosis and Treatment; Recent Literature Review.
    Batash R; Asna N; Schaffer P; Francis N; Schaffer M
    Curr Med Chem; 2017; 24(27):3002-3009. PubMed ID: 28521700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioblastoma: Overview of Disease and Treatment.
    Davis ME
    Clin J Oncol Nurs; 2016 Oct; 20(5 Suppl):S2-8. PubMed ID: 27668386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breaching barriers in glioblastoma. Part I: Molecular pathways and novel treatment approaches.
    Miranda A; Blanco-Prieto M; Sousa J; Pais A; Vitorino C
    Int J Pharm; 2017 Oct; 531(1):372-388. PubMed ID: 28755993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of the Glasgow Prognostic Score for glioblastoma multiforme patients treated with radiotherapy and temozolomide.
    Topkan E; Selek U; Ozdemir Y; Yildirim BA; Guler OC; Ciner F; Mertsoylu H; Tufan K
    J Neurooncol; 2018 Sep; 139(2):411-419. PubMed ID: 29696530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New frontiers for astrocytic tumours.
    Nano R; Lascialfari A; Corti M; Paolini A; Pasi F; Corbella F; DI Liberto R
    Anticancer Res; 2012 Jul; 32(7):2755-8. PubMed ID: 22753735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modernistic and Emerging Developments of Nanotechnology in Glioblastoma-Targeted Theranostic Applications.
    Lakshmi BA; Kim YJ
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent glioblastoma multiforme: a review of natural history and management options.
    Hou LC; Veeravagu A; Hsu AR; Tse VC
    Neurosurg Focus; 2006 Apr; 20(4):E5. PubMed ID: 16709036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic Resonance Nano-Theranostics for Glioblastoma Multiforme.
    Yao J; Hsu CH; Li Z; Kim TS; Hwang LP; Lin YC; Lin YY
    Curr Pharm Des; 2015; 21(36):5256-66. PubMed ID: 26412354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of Magnetic Hyperthermia for Glioblastoma Multiforme Therapy.
    Gupta R; Sharma D
    ACS Chem Neurosci; 2019 Mar; 10(3):1157-1172. PubMed ID: 30715851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Monoclonal Antibodies Delivery for the Glioblastoma Treatment.
    Sousa F; Moura RP; Moreira E; Martins C; Sarmento B
    Adv Protein Chem Struct Biol; 2018; 112():61-80. PubMed ID: 29680243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of nanobiotechnology in the personalized management of glioblastoma multiforme.
    Jain KK
    Nanomedicine (Lond); 2011 Apr; 6(3):411-4. PubMed ID: 21542679
    [No Abstract]   [Full Text] [Related]  

  • 19. Biomarkers and therapeutic advances in glioblastoma multiforme.
    Sasmita AO; Wong YP; Ling APK
    Asia Pac J Clin Oncol; 2018 Feb; 14(1):40-51. PubMed ID: 28840962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New molecularly targeted therapies for glioblastoma multiforme.
    Polivka J; Polivka J; Rohan V; Topolcan O; Ferda J
    Anticancer Res; 2012 Jul; 32(7):2935-46. PubMed ID: 22753758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.